For condition: Psoriasis
The Moderate-to-Severe Plaque Psoriasis Research Study (Up to 82 Weeks)
Study Summary
Who Can Participate?
Adults 18 to 79 years of age with moderate to severe plaque psoriasis may be eligible to participate.
Inclusion Criteria
- Have stable chronic plaque psoriasis (with or without psoriatic arthritis) for at least 6 months
- Moderate-to-severe plaque psoriasis, affecting 10% or more of the body (i.e. 10 handprints)
- Don’t have non-plaque types of psoriasis or drug-induced psoriasis
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialize in treating plaque psoriasis
- Will receive either an investigational injection treatment (active study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Participation will last up to 82 weeks and involve about 15 visits to the study research site.
For more information about this trial, please visit ClinicalTrials.gov
